CollPlant Biotechnologies... (CLGN)
| Bid | 2.2 |
| Market Cap | 28.12M |
| Revenue (ttm) | 515K |
| Net Income (ttm) | -16.61M |
| EPS (ttm) | -1.45 |
| PE Ratio (ttm) | -1.69 |
| Forward PE | -9.62 |
| Analyst | Buy |
| Ask | 2.51 |
| Volume | 6,039 |
| Avg. Volume (20D) | 7,939 |
| Open | 2.48 |
| Previous Close | 2.45 |
| Day's Range | 2.40 - 2.48 |
| 52-Week Range | 2.20 - 6.75 |
| Beta | 0.74 |
About CLGN
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and...
Analyst Forecast
According to 3 analyst ratings, the average rating for CLGN stock is "Buy." The 12-month stock price forecast is $14, which is an increase of 470.26% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago · seekingalpha.com
CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call TranscriptCollPlant Biotechnologies Ltd. (NASDAQ:CLGN ) Q4 2024 Earnings Conference Call March 26, 2025 10:00 AM ET Company Participants Dory Kurowski - LifeSci Advisors Yehiel Tal - CEO Eran Rotem - Deputy CEO...